Estrogen receptors alpha (rs2234693 and rs9340799), and beta (rs4986938 and rs1256049) genes polymorphism in prostate cancer: Evidence for association with risk and histopathological tumor characteristics in Iranian men

Molecular Carcinogenesis

Volumn 51, Issue SUPPL. 1, 2012, Pages

  Safarinejad, Mohammad Reza ^a   Safarinejad, Saba ^a   Shafiei, Nayyer ^a   Safarinejad, Shiva ^a  

^a Clinical Center for Urological Disease Diagnosis   (Iran)

Author keywords

Carcinoma; ER ; ER ; Estrogen receptor; Genetic; Polymorphism; Prostate; Single nucleotide

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING GLOBULIN;

ADULT; ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN BLOOD LEVEL; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

AGED; CASE-CONTROL STUDIES; DNA-CYTOSINE METHYLASES; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; IRAN; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSTATIC NEOPLASMS; RANDOM ALLOCATION; TESTOSTERONE;

EID: 84867139494     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21870     Document Type: Article

References (47)

1. Parkin D, Whelan S, Ferlay J, Raymond L, Young J, editors. Cancer incidence in five continents. VII. Lyon: IARC Scientific Publications; 1997.
2. Hosseini SY, Moharramzadeh M, Ghadian AR, Hooshyar H, Lashay AR, Safarinejad MR. Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran. Int J Urol 2007; 14: 406-411.
3. Safarinejad MR. Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Iran. Ann Oncol 2006; 17: 1166-1171.
4. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
5. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-Analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85.
6. Bosland MC, Ford H, Horton L. Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 b or diethylstilbestrol. Carcinogenesis 1995; 16: 1311-1317.
7. Robertson CN, Roberson KM, Padilla GM, et al. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. J Natl Cancer Inst 1996; 88: 908-917.
8. Langley RE, Godsland IF, Kynaston H, et al. Early hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic prostate cancer. BJU Int 2008; 102: 442-445.
9. Nelles JL, Hu WY, Prins GS. Estrogen action and prostate cancer. Expert Rev Endocrinol Metab 2011; 6: 437-451.
10. Ho SM, Leung YK, Chung I. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer. Ann N Y Acad Sci 2006; 1089: 177-193.
11. Kuiper GG, Gustafsson JA. The novel estrogen receptor-β subtype: Potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett 1997; 410: 87-90.
12. Aléssio AM, Höehr NF, Siqueira LH, Ozelo MC, de Pádua Mansur A, Annichino-Bizzacchi JM. Association between estrogen receptor alpha and beta gene polymorphisms and deep vein thrombosis. Thromb Res 2007; 120: 639-645.
13. Pettersson K, Gustafsson JA. Role of estrogen receptor h in estrogen action. Annu Rev Physiol 2001; 63: 165-192.
14. Rosenkranz K, Hinney A, Ziegler A, et al. Systematic mutation screening of the estrogen receptor beta gene in probands of different weight extremes: Identification of several genetic variants. J Clin Endocrinol Metab 1998; 83: 4524-4527.
15. Hawkins MB, Thornton JW, Crews D, Skipper JK, Dotte A, Thomas P. Identification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleosts. Proc Natl Acad Sci USA 2000; 97: 10751-10756.
16. Taylor AH, Al-Azzawi F. Immunolocalisation of oestrogen receptor β in human tissues. J Mol Endocrinol 2000; 24: 145-155.
17. Imamov O, Morani A, Shim GJ, et al. Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc Natl Acad Sci USA. 2004; 101: 9375-9380.
18. Cheng J, Lee EJ, Madison LD, Lazennec G. Expression of estrogen receptor h in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBSLett 2004; 566: 169-172.
19. Ehara H, Koji T, Deguchi T, et al. Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry. Prostate 1995; 27: 304-313.
20. Bonkhoff H, Fixemer T, Hunsicker I, Remberg K. Estrogen receptor expression in prostate cancer and premalignant prostatic lesions. Am J Pathol 1999; 155: 641-647.
21. Herrington DM, Howard TD, Brosnihan KB, et al. Common estrogen receptor. polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 2002; 105: 1879-1882.
22. Beleza-Meireles A, Omrani D, Kockum I, Frisen L, Lagerstedt K, Nordenskjold A. Polymorphisms of estrogen receptor beta gene are associated with hypospadias. J Endocrinol Invest 2006; 29: 5-10.
23. Maguire P, Margolin S, Skoglund J, et al. Estrogen receptor beta (ESR2) polymorphisms in familial and sporadic breast cancer. Breast Cancer Res Treat 2005; 94: 145-152.
24. American Joint Committee on Cancer (AJCC). TNM Staging Manual. http://www.upmccancercenters.com/cancer/prostate/TNMsystem.html (10 July 2008, date last accessed).
25. Safarinejad MR, Shafiei N, Safarinejad S. Association of polymorphisms in the estrogen receptors alpha, and beta (ESR1, ESR2) with the occurrence of male infertility and semen parameters. J Steroid Biochem Mol Biol 2010; 122: 193-203.
26. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
27. Rokach A, Pollak A, Rosen L, et al. Estrogen receptor alpha gene polymorphisms are associated with the angiographic extent of coronary artery disease. J Clin Endocrinol Metab 2005; 90: 6556-6560.
28. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
29. Gupta L, Thakur H, Sobti RC, Seth A, Singh SK. Role of genetic polymorphism of estrogen receptor-alpha gene and risk of prostate cancer in north Indian population. Mol Cell Biochem 2010; 335: 255-261.
30. Bergner CC, Krause FS, Zugor V, et al. Polymorphisms of human estrogen receptor (ER) gene alpha and beta in prostate cancer PC-EW and PC-OR cell lines. Anticancer Res 2007; 27: 2071-2074.
31. Hedelin M, Bälter KA, Chang ET, et al. Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer. Prostate 2006; 66: 1512-1520.
32. Thellenberg-Karlsson C, Lindström S, Malmer B, et al. Estrogen receptor beta polymorphism is associated with prostate cancer risk. Clin Cancer Res 2006; 12: 1936-1941.
33. Modugno F, Weissfeld JL, Trump DL, et al. Allelic variants of aromatase and the androgen and estrogen receptors: Toward a multigenic model of prostate cancer risk. Clin Cancer Res 2001; 7: 3092-3096.
34. Suzuki K, Nakazato H, Matsui H, et al. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population. Cancer 2003; 98: 1411-1416.
35. Tanaka Y, Sasaki M, Kaneuchi M, Shiina H, Igawa M, Dahiya R. Polymorphisms of estrogen receptor alpha in prostate cancer. Mol Carcinog 2003; 37: 202-208.
36. Fukatsu T, Hirokawa Y, Araki T, et al. Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population. Anticancer Res 2004; 24: 2431-2437.
37. Ellem SJ, Risbridger GP. Aromatase and regulating the estrogen:androgen ratio in the prostate gland. J Steroid Biochem Mol Biol 2010; 118: 246-251.
38. Prins GS. Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression. Endocrinology 1992; 130: 3703-3714.
39. Nevalainen MT, Harkonen PL, Valve EM, Ping W, Nurmi M, Martikainen PM. Hormone regulation of human prostate in organ culture. Cancer Res 1993; 53: 5199-5207.
40. Jarred R, Cancilla B, Prins GS, Thayer K, Cunha GR, Risbridger G. Evidence that estrogens directly alter androgen-regulated prostate development. Endocrinology 2000; 141: 3471-3477.
41. Pasquali D, Rossi V, Esposito D, et al. Loss of estrogen receptor beta expression in malignant human prostate cells in primary cultures and in prostate cancer tissues. J Clin Endocrinol Metab 2001; 86: 2051-2055.
42. Lau K-M, LaSpina M, Long J, Ho S-M. Expression of estrogen receptor (ER)- α and ER-β in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation. Cancer Res 2000; 60: 3175-3182.
43. Ockrim J, Lalani N, Abel P, Therapy Insight: Parenteral estrogen treatment for prostate cancer-A new dawn for an old therapy. Natl Clin Pract Oncol 2006; 3: 552-563.
44. Paech K, Webb P, Kuiper GG, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997; 277: 1508-1510.
45. Leygue E, Dotzlaw H, Watson PH, Murphy LC. Altered estrogen receptor a and b messenger RNA expression during human breast tumorigenesis. Cancer Res 1998; 58: 3197-3201.
46. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW. Selective loss of estrogen receptor b in malignant human colon. Cancer Res 2000; 60: 245-248.
47. Hernández J, Balic I, Johnson-Pais TL, et al. Association between an estrogen receptor alpha gene polymorphism and the risk of prostate cancer in black men. J Urol 2006; 175: 523-527.